Si bone inc   (SIBN)
Other Ticker:  
Price: $17.7600 $-2.78 -13.535%
Day's High: $19.19 Week Perf: -12.47 %
Day's Low: $ 17.30 30 Day Perf: -9.25 %
Volume (M): 1,928 52 Wk High: $ 29.51
Volume (M$): $ 34,236 52 Wk Avg: $21.50
Open: $18.56 52 Wk Low: $15.57

 Market Capitalization (Millions $) 681
 Shares Outstanding (Millions) 38
 Employees -
 Revenues (TTM) (Millions $) 138
 Net Income (TTM) (Millions $) -43
 Cash Flow (TTM) (Millions $) 13
 Capital Exp. (TTM) (Millions $) 8

Si Bone Inc
Si-Bone Inc. is a medical device company that focuses on the development and distribution of minimally invasive surgical devices for the treatment of musculoskeletal disorders. The company was founded in 2008 and is based in Santa Clara, California.

One of Si-Bone's most groundbreaking products is the iFuse Implant System, which is used to treat sacroiliac joint dysfunction. This condition is often caused by damage or degeneration to the sacroiliac joint, which can result in severe lower back pain and negatively impact a patient's quality of life.

The iFuse Implant System consists of a set of triangular shaped implants that are surgically placed across the sacroiliac joint, providing support to the affected area while promoting fusion of the joint. This technology has been proven effective in numerous clinical studies and has been used in thousands of surgical procedures.

In addition to their flagship product, Si-Bone also offers a range of other surgical devices for the treatment of musculoskeletal conditions. These include the iFuse-3D Implant System, which uses three-dimensional printing technology to create custom implants for patients, and the iFuse-CG Implant System, which provides additional compression and stability to the sacroiliac joint.

Si-Bone is known for its commitment to innovation, with a team of talented engineers and researchers constantly working to develop and improve their surgical technologies. The company has also established strong partnerships with leading medical institutions, including the Mayo Clinic and Harvard Medical School.

Si-Bone's products have been widely adopted by healthcare professionals, and the company has received numerous industry accolades for its innovative technologies. They continue to expand their presence in the medical device industry, with a focus on improving patient outcomes and providing minimally invasive solutions for a wide range of musculoskeletal conditions.

   Company Address: 471 El Camino Real Santa Clara 95050 CA
   Company Phone Number: 207-0700   Stock Exchange / Ticker: NASDAQ SIBN
   SIBN is expected to report next financial results on March 01, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Si Bone Inc

SI-BONE, Inc. Surpasses Expectations with Record-Breaking Financial Results

SI-BONE, Inc., a leading medical device company specializing in musculoskeletal disorders of the sacropelvic anatomy, has recently announced its financial results for the fourth quarter and full year ended December 31, 2023. The company reported an improvement in its earnings per share (EPS) compared to the previous year, with a decrease in loss per share from $-0.31 to $-0.24. Additionally, the company saw a sequential improvement in EPS from $-0.25 in the preceding financial reporting period.
One of the highlights of SI-BONE's financial performance was the significant increase in revenue. The company experienced a rapid revenue growth of 21.278%, with revenues reaching $38.75 million in the fourth quarter of 2023 compared to $31.95 million in the same period a year ago. Furthermore, the company's revenue also increased by 14.067% sequentially from $33.97 million.

Product Service News

SI-BONE, Inc. Revolutionizes Sacropelvic Treatment with New Granite Implant System, Accomplishes Substantial Revenue Growth

Published Tue, Jan 30 2024 1:30 PM UTC

SI-BONE, Inc., a leading medical device company focusing on musculoskeletal disorders of the sacropelvic anatomy, has recently received FDA 510(k) clearance for its improved iFuse Bedrock Granite Implant System. This new system features a smaller 9.5 mm diameter, making it more versatile for use in various anatomical conditions. Additionally, the clearance now includes an ex...

Si Bone Inc

Si Bone Inc Achieves Remarkable Revenue Growth in the Third Quarter of 2023, Fueling Optimism for Future Success

Si Bone Inc (NASDAQ: SIBN) is a medical device company that specializes in providing innovative solutions for musculoskeletal disorders of the sacropelvic anatomy. The company recently reported its financial results for the third quarter of 2023, showing significant improvements in various areas.
During the July to September 30, 2023 period, Si Bone Inc reported a decrease in loss per share from $-0.41 to $-0.25 compared to the same quarter a year prior. This improvement in earnings per share (EPS) also reflects a positive trend from the previous quarter, where EPS was reported at $-0.30 per share. The company's efforts to streamline operations and improve efficiency seem to be paying off.

Si Bone Inc

Si Bone Inc Surpasses Expectations with Remarkable Financial Turnaround in Q2 2023

Si Bone Inc, a leading Medical Equipment & Supplies company, has recently released its financial results for the second quarter of 2023. These results indicate several positive developments in terms of earnings, revenue, and stability. Analyzing these facts raises questions about how they will impact the company's future prospects.
1. Improved Earnings:
Si Bone Inc has successfully reduced its loss per share, demonstrating promising growth. Comparing the current loss per share of $-0.30 with $-0.54 from a year ago suggests the company is effectively managing its costs and improving profitability. This trend reflects the organization's ability to adapt and refine its operations in a highly competitive market.

Si Bone Inc

The company disclosed a remarkable accomplishment, over the first quarter of 2023

Si Bone Inc, a leading medical equipment and supplies company, recently reported its financial earnings for the first quarter of 2023. The company?s revenue for this quarter surged by 45.764%, amounting to $32.71 million from the comparable quarter a year ago. Despite this increase in revenue, Si Bone Inc reported a net deficit of $-11.125 million, resulting in a loss of $-0.32 per share.
This loss is slightly higher compared to the prior quarter, where the company recorded a revenue of $31.95 million and a loss of $-0.31 per share. However, when compared to the same quarter a year ago, Si Bone Inc was able to reduce its net deficit from $-17.410 million to $-11.125 million.


Si Bone Inc's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Si Bone Inc does not provide revenue guidance.

Earnings Outlook
Si bone inc does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com